Navigation Links
Sweeping genetic analysis of rare disease yields common mechanism of hypertension
Date:1/22/2012

Analyzing all the genes of dozens of people suffering from a rare form of hypertension, Yale University researchers have discovered a new mechanism that regulates the blood pressure of all humans.

The findings by an international research team headed by Yale scientists, published online Jan. 22 in the journal Nature, may help explain what goes wrong in the one billion people who suffer from high blood pressure. The study also demonstrates the power of new DNA sequencing methods to find previously unknown disease-causing genes.

The team used a technique called whole exome sequencing an analysis of the makeup of all the genes to study a rare inherited form of hypertension characterized by excess levels of potassium in the blood. They found mutations in either of two genes that caused the disease in affected members of 41 families suffering from the condition.

The two genes interact with one another in a complex that targets other proteins for degradation, and they orchestrate the balance between salt reabsorption and potassium secretion in the kidney.

"These genes were not previously suspected to play a role in blood pressure regulation, but if they are lost, the kidney can't put the brakes on salt reabsorption, resulting in hypertension," said Richard Lifton, Sterling Professor and chair of the Department of Genetics at Yale and senior author of the paper.

The mutations had previously been difficult to find because there were very few affected members in each family, so traditional methods to map the genes' locations had been ineffective.

"The mutations in one gene were almost all new mutations found in affected patients but not their parents, while mutations in the other gene could be either dominant or recessive. The exome sequencing technology was ideally suited to cutting through these complexities," said Lynn Boyden of Yale, the first author of the paper.

The next step is to establish how these new components are involved in regulating sodium reabsorption in the kidney, in hopes of finding new ways intervene in hypertension, a major global health problem.

"We are finding all the individual parts to a complicated machine, and we need to understand how they are all put together to make the machine work," said Lifton, who is also an investigator of the Howard Hughes Medical Institute.
'/>"/>

Contact: Bill Hathaway
william.hathaway@yale.edu
203-432-1322
Yale University
Source:Eurekalert

Related biology news :

1. Sweeping view of prostate cancer genome yields deep insights
2. Oil spill reshapes sweeping new study of oyster reefs -- Virginia to Florida
3. Ambry Genetics Reports Results from Clinical Diagnostic Exome™ Testing of Three Patients
4. The power of flowers: Research sprouts a closer look at sunflower genetics
5. Simpler times: Did an earlier genetic molecule predate DNA and RNA?
6. Scientists refute Greenpeace claim that genetically modified corn caused new insect pest
7. Identifying sloth species at a genetic level
8. Cleveland Clinic researcher discovers genetic cause of thyroid cancer
9. DOE researchers achieve important genetic breakthroughs to help develop cheaper biofuels
10. High genetic diversity in an ancient Hawaiian clone
11. New international Ph.D. program on Dynamics of Gene Regulation, Epigenetics and DNA Damage Response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/12/2019)... BEND, Ore. (PRWEB) , ... November 12, 2019 ... ... is launching Cross-Channel Spend Optimizer that improves digital advertising performance up to 25% ... Smart Digital Advertising, Cross-Channel Spend Optimizer uses advanced multi-touch attribution (MTA) to predict ...
(Date:11/11/2019)... ... November 11, 2019 , ... MicroGenDX, ... played a key role in the award-winning study “Next Generation Sequencing for the ... The molecular diagnostic laboratory processed samples using Next Generation DNA Sequencing to examine ...
(Date:11/7/2019)... SCOTTSDALE, Ariz. (PRWEB) , ... November 07, 2019 , ... ... at 50% off through the rest of 2019. The code to use during ... year as well. , R3 is the nation’s leader in regenerative therapies with over ...
Breaking Biology News(10 mins):
(Date:12/4/2019)... ... December 04, 2019 , ... ... enhance dissolution and stabilize amorphous materials. Additionally, their PDF Synchrotron methods provide a ... to describe these compositions both in regulatory and patent applications.  , The latest ...
(Date:12/2/2019)... ... , ... Registration is now open for the American Society of ... Hynes Convention Center May 12-15, 2020, in Boston. The meeting is the premier event ... advocates, and other stakeholders with the goal of advancing gene and cell therapies to ...
(Date:11/22/2019)... ... November 22, 2019 , ... Modality ... step-by-step cold chain validation guide to meet and exceed increasingly stringent regulatory ... chain biopharmaceutical industry leaders, the September 19, 2019 webinar was well received ...
(Date:11/20/2019)... ... November 20, 2019 , ... Defense and aerospace market intelligence ... generation units from 2019-2028. The value of this production is $728 million in ... worth $569 million. , Reference to 2017 is important, as that was ...
Breaking Biology Technology: